Does APALUTAMIDE Cause Interstitial lung disease? 90 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Interstitial lung disease have been filed in association with APALUTAMIDE (ERLEADA). This represents 0.9% of all adverse event reports for APALUTAMIDE.
90
Reports of Interstitial lung disease with APALUTAMIDE
0.9%
of all APALUTAMIDE reports
27
Deaths
58
Hospitalizations
How Dangerous Is Interstitial lung disease From APALUTAMIDE?
Of the 90 reports, 27 (30.0%) resulted in death, 58 (64.4%) required hospitalization, and 12 (13.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for APALUTAMIDE.
What Other Side Effects Does APALUTAMIDE Cause?
Rash (1,117)
Death (1,008)
Fatigue (824)
Hot flush (532)
Product dose omission issue (384)
Diarrhoea (317)
Asthenia (303)
Dizziness (294)
Fall (268)
Off label use (257)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which APALUTAMIDE Alternatives Have Lower Interstitial lung disease Risk?
APALUTAMIDE vs APATINIB
APALUTAMIDE vs APIDRA
APALUTAMIDE vs APIDRA SOLOSTAR
APALUTAMIDE vs APIXABAN
APALUTAMIDE vs APLISOL DIAGNOSTIC ANTIGEN